DAVID SONEGO: Open Payments
NPI 1861496432 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 30 payments from 9 companies in 2025. Trend: 2023 $610 · 2024 $1,026 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 9 | $176 |
| Corium, LLC | 6 | $102 |
| Axsome Therapeutics, Inc. | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| Almatica Pharma LLC | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: Dyanavel XR, Azstarys, Auvelity, FANAPT, LOREEV XR, CAPLYTA, SPRAVATO, REXULTI.
Industry payments across IN — which companies pay providers there.
